Research and development services for predictive analytics point of care system to predict disease severity due to infection
Ended Definitive Contract Awarded Last action
- Contract number
- HDTRA121C0036
- Awardee
-
Prenosis, Inc. UEI F4S5H4BLMZL5
- Awarding agency
-
Defense Threat Reduction Agency
Department of Defense
- Obligated
- $4,308,630
Award facts
- Opportunity
-
- HDTRA120S0001 Solicitation number
- Contract value 100% obligated
- $4,308,629.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 20 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $508,783 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $490,740 | |
| Funding Only Action | $508,783 | |
| Exercise an Option | $550,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $850,324 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,400,000 |
Show all 11
About this award
This federal contract award to Prenosis, Inc., a self-certified small disadvantaged business based in Chicago, Illinois, is for research and development services to develop a predictive analytics point-of-care system to predict disease severity due to infection. The $4,308,629.81 cost-plus-fixed-fee contract was awarded on September 20, 2021 by the Defense Threat Reduction Agency (DTRA), a defense agency, with a period of performance through March 30, 2026. The contract is not set-aside. Prenosis has previously received approximately $1.4 million in grants from the National Institute of General Medical Sciences (NIGMS) to support the development of its Immunix platform, which combines clinical data, biomarkers, and AI-enabled tools to classify sepsis patients for precision treatment. This contract award demonstrates Prenosis' capability to perform advanced research services for federal agencies focused on infectious disease and emergency preparedness.
Quick answers
Who was awarded contract HDTRA121C0036?
HDTRA121C0036 was awarded to Prenosis, Inc. by Defense Threat Reduction Agency (Department of Defense) on September 20, 2021.
How much is contract HDTRA121C0036 worth?
The government has obligated $4,308,630 on HDTRA121C0036.
Was contract HDTRA121C0036 competed?
The extent of competition for HDTRA121C0036 was full and open competition. The government received 20 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award